2026-09-24T14:48:36-05:00 2025-12-31 521392008 GELMAN ROSENBERG & FREEDMAN 4550 MONTGOMERY AVE SUITE 800N BETHESDA MD 208142930 990 2025-01-01 271538205 USAGAINSTALZHEIMER'S ACTION USAG 2024105199 5614 CONNECTICUT AVE NW 288 WASHINGTON DC 20015 MICHAEL CLEARY CFO 2024105199 2026-09-24 1 ELIZABETH W HELLER P00397829 3019519090 2025 MICHAEL CLEARY 5614 CONNECTICUT AVE NW 288 WASHINGTON DC 20015 13615641 0 X WWW.USAGAINSTALZHEIMERSACTION.ORG X 2009 DC SEE PART III, LINE 1. 3 3 0 4 0 0 415535 13555832 0 0 10860 59809 0 0 426395 13615641 0 4000 0 0 31253 194638 0 0 62066 367780 9293665 399033 9492303 27362 4123338 378878 4618021 31224 147029 347654 4470992 X USAGAINSTALZHEIMER'S ACTION IS A RELENTLESS ADVOCACY FORCE COMMITTED TO ENDING ALZHEIMER'S DISEASE. WE PRESS FOR GREATER URGENCY FROM GOVERNMENT, INDUSTRY, AND THE SCIENTIFIC COMMUNITY IN THE DRIVE FOR EFFECTIVE TREATMENTS, PREVENTION, AND ULTIMATELY A CURE. WE ACCOMPLISH THIS THROUGH DETERMINED LEADERSHIP, COLLABORATIVE ADVOCACY, AND STRATEGIC INVESTMENTS. 0 0 9353270 4000 SINCE OUR FOUNDING IN 2010, USAGAINSTALZHEIMER'S ACTION HAS WORKED WITH PEOPLE AND ORGANIZATIONS ACROSS SECTORS TO ACHIEVE MILESTONES, INCLUDING:-ADVOCATING FOR FAMILY CAREGIVERS BY SUPPORTING THE BIPARTISAN CREDIT FOR CAREGIVING ACT, INTRODUCED IN CONGRESS TO PROVIDE UP TO $5,000 IN FEDERAL TAX RELIEF FOR CAREGIVING EXPENSES SUCH AS HOME SAFETY MODIFICATIONS, TRANSPORTATION, AND RESPITE CARE. -JOINING ALMOST 50 PATIENT ADVOCACY ORGANIZATIONS IN CALLING FOR AN IMMEDIATE HALT TO FEDERAL FUNDING AND STAFFING CUTS THAT THREATEN PROGRESS IN ALZHEIMER'S AND DEMENTIA PREVENTION, RESEARCH, CARE, AND TREATMENT. THE COALITION WARNED THAT REDUCTIONS ACROSS KEY HEALTH AGENCIES COULD UNDERMINE DECADES (CONTINUED ON SCHEDULE O)OF BIPARTISAN INVESTMENT AND SLOW ADVANCES THAT MILLIONS OF PATIENTS AND FAMILIES DEPEND ON. POLICYMAKERS WERE PRESSED TO ENGAGE PATIENTS, CAREGIVERS, RESEARCHERS, AND ADVOCATES BEFORE IMPLEMENTING FURTHER CUTS THAT COULD JEOPARDIZE PUBLIC HEALTH AND SCIENTIFIC PROGRESS.-SUPPORTING BIPARTISAN REINTRODUCTION OF THE CONCENTRATING ON HIGH-VALUE ALZHEIMER'S NEEDS TO GET TO AN END (CHANGE) ACT, A MAJOR STEP TOWARD IMPROVING EARLY DETECTION, DIAGNOSIS, AND TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DEMENTIAS. -ADVOCATING TO PROTECT MEDICAID AS A CRITICAL LIFELINE FOR PEOPLE WITH ALZHEIMER'S AND RELATED DEMENTIAS, WARNING THAT PROPOSED RESTRICTIONS COULD LIMIT ACCESS TO ESSENTIAL LONG-TERM CARE FOR MILLIONS. THE ORGANIZATION HAS URGED CONGRESS THROUGH PUBLIC STATEMENTS AND DIRECT ENGAGEMENT TO PRESERVE AND STRENGTHEN MEDICAID AND ENSURE EQUITABLE ACCESS TO CARE FOR AGING AMERICANS.-INCREASING FEDERAL INVESTMENT IN ALZHEIMER'S RESEARCH. USAGAINSTALZHEIMER'S ACTION PLAYED A KEY ROLE IN HELPING HOLD THE BUDGET FOR AD/ADRD RESEARCH STEADY AT THE NATIONAL INSTITUTES OF HEALTH (NIH) IN CALENDAR YEAR 2025. AS A RESPECTED ADVOCATE, USAGAINSTALZHEIMER'S ACTION HAS HELPED DRIVE INCREASES IN NIH AD/ADRD SPENDING FROM $968 MILLION A DECADE EARLIER TO NEARLY $3.8 BILLION IN 2025. 9353270 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 4 0 1 0 0 0 0 0 1 1 0 0 0 X 3 3 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 AL AR CA FL GA HI IL KS KY MD MA MI MN MS NH NJ MN NY NC OR PA RI SC TN UT VA WV WI X MICHAEL CLEARY 2024105199 5614 CONNECTICUT AVE NW 288 WASHINGTON DC 20015 X X GEORGE VRADENBURG CHAIRMAN 2.00 X X 0 0 0 JILL LESSER SECRETARY & TREASURER 1.00 X X 0 0 0 NANCY ZIRKIN BOARD MEMBER 1.00 X 0 0 0 RUSSELL PAULSEN COO (SEE SCHEDULE O) 8.00 X 0 0 0 0 0 0 0 0 0 0 PURPLE STRATEGIES LLC 815 SLATERS LANE ALEXANDRIA VA 22314 COMMUNICATIONS/PAID MEDIA 8723641 GLOBAL STRATEGY GROUP LLC 215 PARK AVENUE SOUTH 15TH FLOOR NEW YORK NY 10003 COMMUNICATIONS/MEDIA 153668 ALSTON & BIRD LLP ONE ATLANTIC CENTER 1201 W PEACHTR ATLANTA GA 30309 LOBBYING AND POLICY WORK 144148 3 13555832 13555832 59809 59809 13615641 0 0 59809 4000 4000 70126 45582 7013 17531 103703 71643 32060 3986 2787 1399 -200 6643 4484 1512 647 10180 6871 2317 992 1824 1824 16244 16244 282853 282853 904733 899185 5548 8005000 8005000 2102 1012 969 121 57462 22982 2732 31748 1316 1060 142 114 4102 3208 495 399 3833 3833 STATE REGISTRATION FEES 10336 10336 PAYROLL FEES 3860 2603 879 378 9492303 9353270 76967 62066 351878 4618021 27000 378878 4618021 31224 147029 31224 147029 X 347654 3714054 756938 347654 4470992 378878 4618021 4123338 0 X 0 1 X 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 WAS PREPARED BY THE OUTSIDE ACCOUNTANTS AND REVIEWED BY ONE OF THE DIRECTORS AND THE CHIEF FINANCIAL OFFICER. A COPY OF THE FORM 990 WAS PROVIDED TO EACH MEMBER OF THE ORGANIZATION'S GOVERNING BODY BEFORE IT WAS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C EACH DIRECTOR, PRINCIPAL OFFICER AND MEMBER OF A COMMITTEE WITH GOVERNING BOARD DELEGATED POWERS ANNUALLY SIGNS A STATEMENT WHICH AFFIRMS THAT HE/SHE: A. HAS RECEIVED A COPY OF THE CONFLICTS OF INTEREST POLICY, B. HAS READ AND UNDERSTANDS THE POLICY, C. HAS AGREED TO COMPLY WITH THE POLICY, AND D. UNDERSTANDS THAT THE ORGANIZATION IS A NON-PROFIT PUBLIC BENEFIT CORPORATION AND, IN ORDER TO MAINTAIN ITS FEDERAL TAX EXEMPTION, IT MUST ENGAGE PRIMARILY IN ACTIVITIES WHICH ACCOMPLISH ONE OR MORE OF ITS TAX-EXEMPT PURPOSES. IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF THE FINANCIAL INTEREST AND BE GIVEN THE OPPORTUNITY TO DISCLOSE ALL MATERIAL FACTS TO THE DIRECTORS AND MEMBERS OF COMMITTEES WITH GOVERNING BOARD DELEGATED POWERS CONSIDERING THE PROPOSED TRANSACTION OR ARRANGEMENT. AFTER DISCLOSURE OF THE FINANCIAL INTEREST AND ALL MATERIAL FACTS, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, HE/SHE LEAVES THE GOVERNING BOARD OR COMMITTEE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. THE REMAINING BOARD OR COMMITTEE MEMBERS DECIDE IF A CONFLICT OF INTEREST EXISTS. FORM 990, PART VI, SECTION C, LINE 19 USAGAINSTALZHEIMER'S ACTION DOES NOT REGULARLY PUBLISH ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, OR FINANCIAL STATEMENTS. HOWEVER, THE ORGANIZATION MAKES SUCH DOCUMENTS AVAILABLE, IF A REQUEST IS MADE BY A MEMBER OF THE PUBLIC. FORM 990, PART VII, LINE 1: USAGAINSTALZHEIMER'S ACTION (USA2ACTION) AND USAGAINSTALZHEIMER'S (USA2), AN UNRELATED ORGANIZATION FOR TAX PURPOSES, HAVE ENTERED INTO A COST-SHARING ARRANGEMENT UNDER WHICH USA2ACTION REIMBURSES USA2 FOR USA2ACTION'S ALLOCABLE SHARE OF THE COMPENSATION OF CERTAIN EMPLOYEES FOR SERVICES PROVIDED TO USA2ACTION. PURSUANT TO THIS AGREEMENT, USA2ACTION REIMBURSED USA2 FOR ITS SHARE OF OFFICER COMPENSATION AS FOLLOWS: RUSSELL PAULSEN: $70,126